SCD5 and rheumatoid arthritis: To determine if there is a correlation between the sCD4 level and the outcome of RA patients, we assessed DAS28 of each RA patients again after 3 months and classified their clinical outcomes into no response, moderate response and good response based on the European League Against Rheumatism (EULAR) response criteria using DAS28.